Dr. Usman Ahmad Shehzad, MD

Dr. Shehzad practices at Bayhealth Hospital, Kent Campus in Dover, Delaware, part of Bayhealth Medical Center.

Dr. Shehzad's NPI, 1043692536, was assigned on June 22, 2015. Dr. Shehzad holds Delaware license C1-0013605.

Dr. Shehzad's primary practice is Bayhealth Hospital, Kent Campus, at 640 S State Street, Dover, DE 19901 in Kent County. The practice phone is (302) 744-7001.

Dr. Shehzad's primary practice is Bayhealth Hospital, Kent Campus in Dover, Delaware, part of Bayhealth Medical Center. Dr. Shehzad is also affiliated with Riddle Hospital. The medical group on file is Bayhealth. Dmand AI also links Dr. Shehzad to 1 more hospital, 1 physician office, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Shehzad practices, 5 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Shehzad's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Shehzad is licensed in Delaware.

CMS data shows 344 Medicare services from Dr. Shehzad across 11 procedure codes in 2024, for 286 Medicare patients. Medicare paid $30,255 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 286 Medicare patients who saw Dr. Shehzad in 2024. The largest group is 65 to 74, with 99 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 30% are also on Medicaid. Their average risk score is 2.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Shehzad's median patient age at 68, with 52% women.

In 2024, Dr. Shehzad wrote 31 Medicare Part D claims for 12 patients. 87% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $224 in total drug cost. In 2022, CMS named 35 claims across 2 drugs.

Dr. Shehzad accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Shehzad, published from 2020 to 2023. Dr. Shehzad's most frequent co-authors are Archana Purushotham, MD, PhD and Abhinay Tumati, MD.

CMS Open Payments shows 3 general payments to Dr. Shehzad from 2 drug and device companies from 2016 to 2022. Food and beverage make up the largest share, 100% of the total. Genentech, Inc. paid the most, $95.